Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Methyl 3-isoquinolinecarboxylate is an organic compound with the chemical formula C11H9NO2. It is a derivative of isoquinoline, featuring a methyl ester group attached to the 3-position of the isoquinoline ring. Methyl 3-isoquinolinecarboxylate is characterized by its cream powder appearance and is known for its chemical properties that make it suitable for various applications in different industries.

27104-73-0

Post Buying Request

27104-73-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27104-73-0 Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-isoquinolinecarboxylate is used as an intermediate in the synthesis of various pharmaceutical compounds. Its ability to be converted into other bioactive molecules makes it a valuable component in the development of new drugs.
Used in Chemical Synthesis:
Methyl 3-isoquinolinecarboxylate serves as a key building block in the preparation of various organic compounds, including 3-acetylisoquinoline. This application takes advantage of its reactivity and structural features to create a wide range of products with diverse properties and potential uses.
Used in Research and Development:
Due to its unique chemical structure, Methyl 3-isoquinolinecarboxylate is utilized in research and development for the exploration of new chemical reactions, synthesis methods, and potential applications in various fields, including material science, pharmaceuticals, and agrochemicals.

Synthesis Reference(s)

Journal of Medicinal Chemistry, 25, p. 1081, 1982 DOI: 10.1021/jm00351a015

Check Digit Verification of cas no

The CAS Registry Mumber 27104-73-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,1,0 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 27104-73:
(7*2)+(6*7)+(5*1)+(4*0)+(3*4)+(2*7)+(1*3)=90
90 % 10 = 0
So 27104-73-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H9NO2/c1-14-11(13)10-6-8-4-2-3-5-9(8)7-12-10/h2-7H,1H3

27104-73-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B20181)  Methyl isoquinoline-3-carboxylate, 98%   

  • 27104-73-0

  • 1g

  • 583.0CNY

  • Detail
  • Alfa Aesar

  • (B20181)  Methyl isoquinoline-3-carboxylate, 98%   

  • 27104-73-0

  • 5g

  • 2454.0CNY

  • Detail
  • Alfa Aesar

  • (B20181)  Methyl isoquinoline-3-carboxylate, 98%   

  • 27104-73-0

  • 25g

  • 10450.0CNY

  • Detail
  • Aldrich

  • (338559)  Methyl3-isoquinolinecarboxylate  98%

  • 27104-73-0

  • 338559-1G

  • 580.32CNY

  • Detail

27104-73-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl isoquinoline-3-carboxylate

1.2 Other means of identification

Product number -
Other names 3-carbomethoxy-isochinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27104-73-0 SDS

27104-73-0Relevant articles and documents

A new (3+3) annulation route to isoquinoline-3-carboxylates

Chattopadhyay, Shital K,Maity, Susama,Pal, Benoy K,Panja, Srikanta

, p. 5079 - 5081 (2002)

A new synthesis of isoquinoline-3-carboxylates based on the palladium(0)-catalysed Heck-type arylation of 2-amidoacrylates with the appropriate 2-substituted iodobenzene is reported.

β-Carbolines: Synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors

Cain,Weber,Guzman,Cook,Barker,Rice,Crawley,Paul,Skolnick

, p. 1081 - 1091 (1982)

The authors have prepared a series of tetrahydro-β-carbolines (THβC), β-carbolines (β-C), and other nitrogen heterocycles and evaluated them in vitro with respect to their ability to bind to benzodiazepine receptors. The fully aromatic β-C's were more pot

Palladium-catalysed cascades triggered by dehydrogenation of secondary or tertiary amines: Access to bridged- and fused-ring heterocycles

Grigg, Ronald,Somasunderam, Anoma,Sridharan, Visuvanathar,Keep, Ann

, p. 97 - 99 (2009)

Palladium-catalysed cascades triggered by dehydrogenation of secondary or tertiary amines and trapping the intermediate imines with cycloadditions and Mannich reactions result in a range of bridged- and fused-ring heterocyclic motifs in moderate to good y

Synthesis and assay of isoquinoline derivatives as HIV-1 Tat-TAR interaction inhibitors

He, Meizi,Yuan, Dekai,Lin, Wei,Pang, Ruifang,Yu, Xiaolin,Yang, Ming

, p. 3978 - 3981 (2005)

Four new isoquinoline derivatives bearing guanidinium group or amino group-terminated side chain were synthesized to target the HIV-1 TAR element. Their abilities to bind TAR RNA and inhibit Tat-TAR RNA interaction were determined by CE analysis, a Tat-dependent HIV-1 LTR-driven CAT assay and SIV-induced syncytium evaluation.

A chromone hydrazide Schiff base fluorescence probe with high selectivity and sensitivity for the detection and discrimination of human serum albumin (HSA) and bovine serum albumin (BSA)

Yan, Xiao-Jing,Li, Zhe,Liu, Hai-Bo,Wang, Zhi-Gang,Fan, Jing,Xie, Cheng-Zhi,Li, Qing-Zhong,Xu, Jing-Yuan

, (2021/10/12)

The discrimination and identification of human serum albumin (HSA) and bovine serum albumin (BSA) is very important, which is due to the vital roles of two SAs in biological and pharmaceutical research. Based on structural screening and docking calculation from a series of homologues, a coumarin Schiff base fluorescent probe 3-hydroxy-N′-((4-oxo-4H-chromen-3-yl)methylene)-2-naphthohydrazide (HCNH) has been designed and synthesized, which could effectively discriminate HSA and BSA. The probe HCNH exhibited superior sensitivity toward HSA and BSA with the detection limits of 10.62 nM and 16.03 nM in PBS solution, respectively. The binding mechanism of HCNH with SAs was studied by Job's plot analysis, SA destruction and displacement assay. Molecular docking and DFT methods were utilized to provide deep insight into the spatial conformation change of HCNH and binding sites in HSA/BSA. The conformation of HCNH was significantly influenced by the microenvironment provided by HSA and BSA, therefore its fluorescence emission was affected correspondingly. Non-toxic probe HCNH could be successfully used for fluorescence bio-imaging of HSA in cancer cells, which is significantly different from normal cells and favors the application in medical diagnosis.

Electrochemical Deoxygenation of N-Heteroaromatic N -Oxides

Xu, H.-C.,Xu, P.

supporting information, p. 1219 - 1221 (2019/06/08)

An electrochemical method for the deoxygenation of N-heteroaromatic N -oxide to give the corresponding N-heteroaromatics has been developed. Several classes of N-heterocycles such as pyridine, quinoline, isoquinoline, and phenanthridine are tolerated. The electrochemical reactions proceed efficiently in aqueous solution without the need for transition-metal catalysts and waste-generating reducing reagents.

Design and Discovery of Novel Chiral Antifungal Amides with 2-(2-Oxazolinyl)aniline as a Promising Pharmacophore

Zhang, Lu,Li, Wei,Xiao, Taifeng,Song, Zehua,Csuk, René,Li, Shengkun

, p. 8957 - 8965 (2018/09/10)

Inspired by established succinate dehydrogenase inhibitors (SDHIs), our continuing efforts toward the discovery of chiral antifungal amides turned to the optimization of their polar regions with 2-(2-oxazolinyl)aniline as a known pharmacophore. Scaffold hopping and bioactivity-guided convergent synthesis enabled the identification of promising antifungal categories. Fine tuning of the substituents and chirality furnished seven amides (1s, 1t, 2d, 2h, 2j, 3k, and 2l) as antifungal candidates, with EC50 values lower than 5 mg/L. The first investigation of chiral amides of acyclic acids as SDHIs was conducted, and compound 2d was selected as a promising candidate against Botrytis cinerea, with a preventative efficacy of up to 93.9% at 50 mg/L, which is better than that of boscalid. The different binding models between compounds with different configurations were simulated for compound 2d and its diastereoisomers. The benefits of synthetic accessibility and cost-effectiveness highlight the practical potential for compound 2d as a good alternative to known SDHI fungicides.

Imidazole-containing condensed tricyclic compound and application thereof

-

Paragraph 0383, (2018/03/01)

The invention discloses an imidazole-containing condensed tricyclic compound adopting the structure as shown in the formula (I) or pharmaceutically acceptable salts, stereisomers or prodrug molecules thereof. The imidazole-containing condensed tricyclic compound has the IDO1 activity regulation function, can enhance T-cell activation through blocking immune checkpoints IDO1, is used for treating IDO1-mediated immunosuppression, and therefore, can become an effective medicine for treating malignant tumors. When used together with checkpoint protein anti-body drugs or other anti-cancer drugs, the imidazole-containing condensed tricyclic compound can enhance the anti-cancer effect. Meanwhile, the imidazole-containing condensed tricyclic compound has the potential of effectively treating IDO1 abnormity related immunosuppressive diseases and has a high application value.

Development of a metal-free amine oxidation method utilizing DEAD chemistry

Wang,Piva De Silva,Wiebe,Fehr,Davis

, p. 48848 - 48852 (2017/11/06)

Herein, we examine the oxidative abilities of azodicarboxylates for the conversion of amines to imines. This method provides access to synthetically useful imine intermediates including β-carbolines, quinazolines and N-heterocyclic carbene precursors. The ability to recover spent azodicarboxylate for regeneration and further use underscores the applicability and appeal of this protocol.

Environment-responsive multivalent isoquinoline-3-carboxylic acid conjugate, and preparation method and application thereof

-

Paragraph 0023; 0031; 0032, (2017/09/01)

The invention discloses an environment-responsive multivalent isoquinoline-3-carboxylic acid conjugate, and a preparation method and application thereof, belonging to the field of isoquinoline-3-carboxylic acid conjugates. According to the invention, 3,3'-dithiopropane diacid is used as a linking arm for coupling four isoquinoline-3-carboxylic acids with tris(2-aminoethyl)amine so as to form an isoquinoline derivative; multivalent synergism of a plurality of pharmacophores on a drug carrier is exerted on the lesion site of a tumor, so the antitumor activity of the antitumor drug is substantially improved; and through the environmental redox response of a disulfide bond to tumors, intelligent targeted release of the antitumor drug to a tumor part is realized, and toxicity of the antitumor drug to normal tissue is effectively reduced.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27104-73-0